CVC Catalyst III backs WillowWood Holdings
The Mount Sterling, Ohio-based prosthetics device manufacturer is being sold by Blue Sea Capital, the Arbogast family, and management, who are reinvesting alongside CVC Catalyst.
Takeaways
- The target serves prosthetics and limb loss care across United States.
- Accelerate growth through R&D, new product innovation, international expansion, and active M&A strategy.
CVC Catalyst has taken a majority stake in WillowWood Holdings, a Mount Sterling, Ohio-based manufacturer of prosthetic products and pioneer of the gel liner.
The company’s lineup includes prosthetic liners, feet, knees, and fabrication technologies, with distribution in the United States and key European markets.
Blue Sea Capital, the Arbogast family, and management are reinvesting alongside CVC and will retain significant stakes in the 115-year-old company.
Co-CEOs Mahesh Mansukhani and Daniel Rubin will continue to lead the business, with fourth-generation family member Ryan Arbogast remaining in a supporting role.
“Since partnering with the Arbogast family in 2018, Daniel and I have been proud to build WillowWood into a leader in prosthetic products.
This next chapter with CVC is about accelerating what we have built – bringing new products to patients faster and expanding internationally.
We are grateful to Blue Sea Capital for their support and excited for what lies ahead,” said Mahesh Mansukhani, Chief Executive Officer of WillowWood.
CVC Catalyst plans to accelerate growth through new product launches, building a direct commercial footprint in Europe, and pursuing an active M&A strategy.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.